Skip to content

Clinical trials

Recruiting Lung Diseases, Interstitial trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases, Interstitial Status: Recruiting Country / region: Canada Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20211
20231
20246
20254
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting16

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim2
Centre hospitalier de l'Université de Montréal (CHUM)2
University of British Columbia2
AllRock Bio, Inc.1
Contineum Therapeutics1
David Palma1
GlaxoSmithKline1
Liquidia Technologies, Inc.1
McGill University Health Centre/Research Institute of the McGill University Health Centre1
United Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases, Interstitial16
Idiopathic Pulmonary Fibrosis3
Hypertension, Pulmonary2
Pulmonary Disease, Chronic Obstructive2
Pulmonary Fibrosis2
Scleroderma, Systemic2
Alveolitis, Extrinsic Allergic1
Autoimmune Diseases1
Connective Tissue Diseases1
Hereditary Sensory and Autonomic Neuropathies1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.